Announcement of the 10th webinar in the series on "Analysis of Lipid Nanoparticles (LNP) Gaining Attention as Nucleic Acid DDS and Quality Evaluation Methods for Underlying Biologics and Medium-sized Pharmaceuticals" to be held on January 31, 2024 (Wednesday).

Sperapharma Co., Ltd. will hold the 10th webinar in its series titled "Analysis of Lipid Nanoparticles (LNP) that have begun to attract attention as Nucleic Acid DDS and Quality Evaluation Methods for the Underlying Bio and Mid-sized Pharmaceuticals."
This webinar is recommended for those involved in the development of bio and mid-sized pharmaceuticals and LNP formulations, as well as those interested in our contract services and initiatives.
In this webinar, we will introduce an overview of the quality evaluation methods for LNP formulations based on the analytical techniques for bio pharmaceuticals and mid-sized pharmaceuticals, which serve as the foundation for the required quality evaluation technologies for LNP formulations, along with the services we provide.
We sincerely look forward to your participation.

Date and time | Wednesday, Jan 31, 2024 11:00 AM ~ The end time is 11:40. |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration